MediQuest Announces Sale of Late Stage Onychomycosis Program to EFFELL…

MediQuest Therapeutics announces the sale of late stage Onychomycosis/Onycholysis programs to EFFELL LLC, the first in a series of asset sales.

(PRWeb September 19, 2012)

Read the full story at http://www.prweb.com/releases/2012/9/prweb9911525.htm

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: